| Levetiracetam |
EU/1/00/146/030 |
Keppra, Concentrate for solution for infusion, 100 mg/ml- 5 ml, mg, Pack: 10 |
UCB Pharma GmbH, Германия |
UCB Pharma SA, Belgium |
264.04 |
52.81 |
316.85 |
6% |
15 |
279.04 |
55.81 |
334.85 |
18% |
30 |
309.04 |
61.81 |
370.85 |
|
КЦ-520/09.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
3014 |
| Levetiracetam |
EU/1/00/ 146/027 |
Keppra, Oral solution, 100 mg/ml - 300 ml, mg, Pack: 1 |
UCB Pharma SA, Белгия |
UCB Pharma SA Allee de la Recherche 60 B-1070 Brussels, Belgium |
48.86 |
9.77 |
58.63 |
4% |
1.95 |
50.81 |
10.16 |
60.97 |
16% |
7.82 |
58.63 |
11.73 |
70.36 |
|
НСР-3969/30.06.2014 |
15.07.2014 |
15.07.2014 |
Активен |
3013 |
| Levetiracetam |
EU/1/00/146/027 |
Keppra, Oral solution, 100 mg/ml - 300 ml, mg, Pack: 1 |
UCB Pharma SA, Белгия |
UCB Pharma SA Allee de la Recherche 60 B-1070 Brussels, Belgium |
53.2 |
10.64 |
63.84 |
4% |
2.13 |
55.33 |
11.07 |
66.4 |
16% |
8.51 |
63.84 |
12.77 |
76.61 |
|
НСР-1617/01.11.2013 |
18.11.2013 |
18.11.2013 |
Неактивен |
3013 |
| Levetiracetam |
EU/1/00/146/027 |
Keppra, Oral solution, 100 mg/ml - 300 ml, mg, Pack: 1 |
UCB Pharma SA, Белгия |
UCB Pharma SA Allee de la Recherche 60 B-1070 Brussels, Belgium |
71.51 |
14.3 |
85.81 |
4% |
2.86 |
74.37 |
14.87 |
89.24 |
16% |
11.44 |
85.81 |
17.16 |
102.97 |
|
КЦРР-1097/26.07.2012 |
17.08.2012 |
17.08.2012 |
Неактивен |
3013 |
| Levetiracetam |
EU/1/00/146/027 |
Keppra, Oral solution, 100 mg/ml - 300 ml, mg, Pack: 1 |
UCB Pharma SA, Белгия |
NextPharma SAS, France |
115.53 |
23.11 |
138.64 |
6% |
6.93 |
122.46 |
24.49 |
146.95 |
18% |
20.8 |
143.26 |
28.65 |
171.91 |
|
КЦ-520/09.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
3013 |
| Ketoprofen |
20011125 |
Ketonal, Capsule, hard, 50 mg, mg, Pack: 25 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
2.05 |
0.41 |
2.46 |
7% |
0.14 |
2.19 |
0.44 |
2.63 |
20% |
0.41 |
2.6 |
0.52 |
3.12 |
|
КЦ-527/13.02.2009; НСР-10082/18.08.2016 |
02.03.2009 |
02.10.2016 |
Заличен |
525 |
| Ketoprofen |
ІІ-15902/29.12.2006 г. |
Ketonal, Capsule, hard, 50 mg, mg, Pack: 25 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
2.05 |
0.41 |
2.46 |
7% |
0.14 |
2.19 |
0.44 |
2.63 |
20% |
0.41 |
2.6 |
0.52 |
3.12 |
|
КЦ-527/13.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
525 |
| Ketoprofen |
ІІ-15905/29.12.2006 |
KETONAL, Solution for injection, 100 mg/2 ml, mg, Pack: 50 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
117.94 |
23.59 |
141.53 |
4% |
4.72 |
122.66 |
24.53 |
147.19 |
16% |
18.87 |
141.53 |
28.31 |
169.84 |
|
КЦ-1698/25.06.2010 |
15.07.2010 |
15.07.2010 |
Активен |
954 |
| Ketoprofen |
20080267 |
Ketoprofen-Tchaikapharma, Solution for injection, 100 mg/2 ml, mg, Pack: 90 |
Чайкафарма Висококачествените лекарства АД, България |
„Чайкафарма Висококачествените Лекарства“ АД, България |
212.29 |
42.46 |
254.75 |
4% |
8.49 |
220.78 |
44.16 |
264.94 |
16% |
25 |
245.78 |
49.16 |
294.94 |
корекц. Решение НСР-6043/16.04.2015 |
НСР-5762/09.03.2015 |
23.03.2015 |
23.03.2015 |
Активен |
3644 |
| Ketoprofen |
II-3770/12.12.2008 г. |
Ketoprofen-Tchaikapharma, Solution for injection, 100 mg/2 ml, mg, Pack: 100 |
Чайкафарма Висококачествените лекарства АД, България |
Чайкафарма Висококачестве-ните Лекарства АД, гр. Пловдив |
120 |
24 |
144 |
4% |
4.8 |
124.8 |
24.96 |
149.76 |
16% |
19.2 |
144 |
28.8 |
172.8 |
цената е заличена с решение НСР-6256/21.05.2015 (в сила от 16.06.2015 ) |
КЦ-628/27.02.2009 |
19.03.2009 |
19.03.2009 |
Заличен |
568 |
| Amino acids |
ІІ-5476/7.8.2009 |
Ketosteril Ketoacid, Film coated tablet, , -, Pack: 100 |
Фрезениус Каби България ЕООД, България |
Fresenius Kabi Deutachland GmbH Germany; LABESFAL - Laboratorios Almiro S.A, Португалия |
77.1 |
15.42 |
92.52 |
4% |
3.08 |
80.18 |
16.04 |
96.22 |
16% |
12.34 |
92.52 |
18.5 |
111.02 |
|
НСР-7524/19.11.2015. |
05.12.2015 |
05.12.2015 |
Активен |
3478 |
| Amino acids |
ІІ-5476/7.8.2009 |
Ketosteril Ketoacid, Tablet, 67 mg alfa-ketoanalogue to isoleucine; 101 mg alfa-ketoanalogue to leucine; 68 mg alfa-ketoanalogue to phenyl alanine; 86 mg alfa-ketoanalogue to valine; 59 mg alfa-hydroxyanalogue to methionine; 105 mg L-lysine; 53 mg L-threonine; 23 mg L-thryptophan; 38, mg, Pack: 100 |
Фрезениус Каби България ЕООД, България |
Fresenius Kabi Deutachland GmbH Germany; LABESFAL - Laboratorios Almiro S.A, Португалия |
77.2 |
15.44 |
92.64 |
4% |
3.09 |
80.29 |
16.06 |
96.35 |
16% |
12.35 |
92.64 |
18.53 |
111.17 |
Протокол № 101/29.01.2015 |
НСР-5286/ 18.12.2014. |
01.01.2015 |
01.01.2015 |
Неактивен |
3478 |
| Amino acids |
ІІ-5476/07.08.2009 |
Ketosteril Ketoacid, Tablet, 67 mg alfa-ketoanalogue to isoleucine; 101 mg alfa-ketoanalogue to leucine; 68 mg alfa-ketoanalogue to phenyl alanine; 86 mg alfa-ketoanalogue to valine; 59 mg alfa-hydroxyanalogue to methionine; 105 mg L-lysine; 53 mg L-threonine; 23 mg L-thryptophan; 38, mg, Pack: 100 |
Фрезениус Каби България ЕООД, България |
Fresenius Kabi Deutachland GmbH Germany; LABESFAL - Laboratorios Almiro S.A, Португалия |
79.99 |
16 |
95.99 |
4% |
3.2 |
83.19 |
16.64 |
99.83 |
16% |
12.8 |
95.99 |
19.2 |
115.19 |
промяна в обстоятелства КЦPP-1465/02.10.2012 |
КЦ-1162/07.10.2009 |
26.10.2009 |
26.10.2009 |
Неактивен |
3478 |
| Рembrolizumab |
EU/1/15/1024/001 |
Keytruda, Powder for concentrate for solution for infusion, 50, mg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
Schering-Plough Labo NV, Industriepark 30 Heist-op-den-Berg B-2220, Белгия |
3396.2 |
679.24 |
4075.44 |
4% |
10 |
3406.2 |
681.24 |
4087.44 |
16% |
25 |
3431.2 |
686.24 |
4117.44 |
|
НСР-7751/18.12.2015. (допуска предварително изпълнение); HCP-10161/31.08.2016 |
02.10.2016 |
02.10.2016 |
Активен |
4157 |
| Рembrolizumab |
EU/1/15/1024/001 |
Keytruda, Powder for concentrate for solution for infusion, 50, mg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
Schering-Plough Labo NV, Industriepark 30 Heist-op-den-Berg B-2220, Белгия |
3491.16 |
698.23 |
4189.39 |
4% |
10 |
3501.16 |
700.23 |
4201.39 |
16% |
25 |
3526.16 |
705.23 |
4231.39 |
|
НСР-7751/18.12.2015. (допуска предварително изпълнение) |
18.12.2015 |
18.12.2015 |
Неактивен |
4157 |
| Immunoglobuline, normal human for extravascular adm. |
EU/1/05329/004 |
KIOVIG, Solution for infusion, 10 g/100 ml(100 mg/ml), mg, Pack: 1 |
Baxter AG, Австрия |
BAXTER SA - Belgium |
754.21 |
150.84 |
905.05 |
6% |
15 |
769.21 |
153.84 |
923.05 |
18% |
30 |
799.21 |
159.84 |
959.05 |
цената е заличена с решение КЦРР-770/07.06.2012 |
КЦРР-430/19.04.2012 |
27.06.2012 |
27.06.2012 |
Заличен |
1170 |
| Immunoglobuline, normal human for extravascular adm. |
EU/1/05329/004 |
KIOVIG, Solution for infusion, 20 g/ 200 ml (100 mg/ ml), mg, Pack: 1 |
Baxter AG, Австрия |
BAXTER SA - Belgium |
1570.16 |
314.03 |
1884.19 |
6% |
15 |
1585.16 |
317.03 |
1902.19 |
18% |
30 |
1615.16 |
323.03 |
1938.19 |
цената е заличена с решение КЦРР-770/07.06.2012 |
КЦРР-430/19.04.2012 |
27.06.2012 |
27.06.2012 |
Заличен |
1171 |
| Immunoglobuline, normal human for extravascular adm. |
EU/1/05329/002 |
KIOVIG, Solution for infusion, 2.5 g/25 ml (100 mg/ml), mg, Pack: 1 |
Baxter AG, Австрия |
BAXTER SA - Belgium |
174.87 |
34.97 |
209.84 |
6% |
10.49 |
185.36 |
37.07 |
222.43 |
18% |
30 |
215.36 |
43.07 |
258.43 |
цената е заличена с решение КЦРР-770/07.06.2012 |
КЦРР-430/19.04.2012 |
27.06.2012 |
27.06.2012 |
Заличен |
1168 |
| Immunoglobuline, normal human for extravascular adm. |
EU/1/05329/003 |
KIOVIG, Solution for infusion, 5 g/ 50 ml (100 mg/ ml), mg, Pack: 1 |
Baxter AG, Австрия |
BAXTER SA - Belgium |
376.63 |
75.33 |
451.96 |
6% |
15 |
391.63 |
78.33 |
469.96 |
18% |
30 |
421.63 |
84.33 |
505.96 |
цената е заличена с решение КЦРР-770/07.06.2012 |
КЦРР-430/19.04.2012 |
27.06.2012 |
27.06.2012 |
Заличен |
1169 |
| Immunoglobuline, normal human for extravascular adm. |
EU/1/05329/001 |
KIOVIG, Solution for infusion, 1 g/ 10 ml, mg, Pack: 1 |
Baxter AG, Австрия |
BAXTER SA - Belgium |
69.41 |
13.88 |
83.29 |
6% |
4.16 |
73.57 |
14.71 |
88.28 |
18% |
12.49 |
86.06 |
17.21 |
103.27 |
цената е заличена с решение КЦРР-770/07.06.2012 |
КЦРР-430/19.04.2012 |
27.06.2012 |
27.06.2012 |
Заличен |
1167 |
| Immunoglobuline, normal human for extravascular adm. |
EU/1/05/329/005 |
KIOVIG, Solution for infusion, 20 g/ 200 ml (100 mg/ ml), mg, Pack: 1 |
Baxter AG, Австрия |
BAXTER SA - Belgium |
1599.87 |
319.97 |
1919.84 |
6% |
15 |
1614.87 |
322.97 |
1937.84 |
18% |
30 |
1644.87 |
328.97 |
1973.84 |
|
КЦ-1336/28.01.2010 |
17.02.2010 |
17.02.2010 |
Неактивен |
1171 |
| Immunoglobuline, normal human for extravascular adm. |
EU/1/05/329/003 |
KIOVIG, Solution for infusion, 5 g/ 50 ml (100 mg/ ml), mg, Pack: 1 |
Baxter AG, Австрия |
BAXTER SA - Belgium |
399.97 |
79.99 |
479.96 |
6% |
15 |
414.97 |
82.99 |
497.96 |
18% |
30 |
444.97 |
88.99 |
533.96 |
|
КЦ-1336/28.01.2010 |
17.02.2010 |
17.02.2010 |
Неактивен |
1169 |
| Immunoglobuline, normal human for extravascular adm. |
EU/1/05/329/004 |
KIOVIG, Solution for infusion, 10 g/100 ml(100 mg/ml), mg, Pack: 1 |
Baxter AG, Австрия |
BAXTER SA - Belgium |
799.93 |
159.99 |
959.92 |
6% |
15 |
814.93 |
162.99 |
977.92 |
18% |
30 |
844.93 |
168.99 |
1013.92 |
|
КЦ-1336/28.01.2010 |
17.02.2010 |
17.02.2010 |
Неактивен |
1170 |
| Immunoglobuline, normal human for extravascular adm. |
EU/1/05/329/001 |
KIOVIG, Solution for infusion, 1 g/ 10 ml, mg, Pack: 1 |
Baxter AG, Австрия |
BAXTER SA - Belgium |
79.99 |
16 |
95.99 |
6% |
4.8 |
84.79 |
16.96 |
101.75 |
18% |
14.4 |
99.19 |
19.84 |
119.03 |
|
КЦ-1336/28.01.2010 |
17.02.2010 |
17.02.2010 |
Неактивен |
1167 |
| Immunoglobuline, normal human for extravascular adm. |
EU/1/05/329/002 |
KIOVIG, Solution for infusion, 2.5 g/25 ml (100 mg/ml), mg, Pack: 1 |
Baxter AG, Австрия |
BAXTER SA - Belgium |
199.98 |
40 |
239.98 |
6% |
12 |
211.98 |
42.4 |
254.38 |
18% |
30 |
241.98 |
48.4 |
290.38 |
|
КЦ-1336/28.01.2010 |
17.02.2010 |
17.02.2010 |
Неактивен |
1168 |